Endpoints
Efficacy endpoint was freedom from AF or other supraventricular
arrhythmias (lasting >30 seconds) at 1-year follow-up.
Because early recurrences of AF may be a transient phenomenon, a
3-months blanking period was used. Safety endpoints were incidence of
mortality, morbidity or other procedure-related complications.